title: Left main percutaneous coronary intervention.
abstract: The introduction of drug-eluting stents and advances in catheter techniques have led to increasing acceptance of percutaneous coronary intervention (PCI) as a viable alternative to coronary artery bypass graft (CABG) for unprotected left main disease. Current guidelines state that it is reasonable to consider unprotected left main PCI in patients with low to intermediate anatomic complexity who are at increased surgical risk. Data from randomized trials involving patients who are candidates for either treatment strategy provide novel insight into the relative safety and efficacy of PCI for this lesion subset. Herein, we review the current data comparing PCI with CABG for left main disease, summarize recent guideline recommendations, and provide an update on technical considerations that may optimize clinical outcomes in left main PCI.
authors.affiliation: Scripps Clinic and Scripps Translational Science Institute, La Jolla, California, USA.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Teirstein
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Price
mesh_terms: D003324:Coronary Artery Disease / Q000628:therapy*; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D016896:Treatment Outcome